Merus N.V. announces public offering of 5.26M shares at $57.00/share, expects ~$281.7M net proceeds

Merus N.V.

Underwritten public offering of 5,263,158 common shares at $57.00/share; underwriters have 30-day option for 789,473 additional shares.
Net proceeds expected ~$281.7M after discounts and expenses; closing expected June 5, 2025.
Proceeds to fund clinical development, preclinical research, and working capital; cash runway extended into 2028.
Underwriting agreement with Jefferies, BofA, Leerink, Guggenheim, Truist as representatives.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.